🔎 Trials Near Me

Home › Cancro pancreatico › New York

Studi clinici su Cancro pancreatico nello stato di New York

68 studi su Cancro pancreatico cercano partecipanti presso sedi nello stato di New York.

Città nello stato di New York

Testo ufficiale dello studio (inglese)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07562152

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

  • Kings County Hopsital Center, Brooklyn
  • Queens Cancer Center of Queens Hospital, Jamaica
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
  • e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT04751435

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  • Columbia University Irving Medical Center, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • NYU Langone Medical Center, New York
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Icahn School of Medicine at Mount Sinai, New York
  • University of Rochester Medical Center, Rochester
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center, New York
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07409272

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Northwell Health / RJ Zuckerberg Cancer Center, Lake Success
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center Main Campus, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06445062

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US059, Lake Success
  • Investigative Site US031, New York
  • Investigative Site US003, New York
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07522073

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • NYU Langone Health Perlmutter Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07629960

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07450859

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07349537

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0142, Buffalo
  • Local Institution - 0170, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07492680

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06400472

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Roswell Park Cancer Institute, Buffalo
  • Glens Falls Hospital, Glens Falls
  • Northwell Health/Center for Advanced Medicine, Lake Success
  • e altri 6
In reclutamentoStudio osservazionale
Età da 50 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT04239573

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • NYU-Manhattan, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07644559

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • Northwell Health Zuckerberg Cancer Center, Lake Success
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06673017

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05837767

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
  • David H Koch, Memorial Sloan Kettering Cancer Center, New York
  • New york cancer and blood specialists - Oncology, Port Jefferson Station
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05245500

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • Mount Sinai Hospital, New York
  • NYP/Weill Cornell Medical Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT04172532

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • New York Cancer & Blood Specialists, New York
  • University of Rochester - Wilmot Cancer Institute, Rochester
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT06582017

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  • Bassett Healthcare Network, Cooperstown
  • NYU Langone Health, New York
  • Lenox hill Hospital, New York
  • e altri 1
In reclutamento
Età da 18 a 120 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT06698458

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • e altri 11
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT06958328

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

  • Roswell Park Cancer Institute, Buffalo
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07214298

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

  • Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor
  • Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • e altri 4
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT03334708

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, New York
  • Research Site, New York
In reclutamentoFase 1/2
Età da 18 a 130 · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT05417594

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06242470

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

  • SUNY Downstate Health Sciences University, Brooklyn
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06030622

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #103, New York
  • Investigative Site #106, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 lug 2026 · NCT06545942

Pancreatic Cancer Early Detection Consortium

  • Memorial Sloan Kettering Cancer Center, New York
  • Icahn School of Medicine At Mount Sinai, New York
  • Columbia University Irving Medical Center, New York
  • e altri 2
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 18 a 90 · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT04970056

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • NYU Langone Health Perlmutter Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06937177

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 lug 2026 · NCT06695845

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

  • Memorial Sloan Kettering Suffolk-Commack (Consent only), Commack
  • Memorial Sloan Kettering Westchester (Consent only), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
  • e altri 1
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT07612046

EXoPERT EMERALD Clinical Study

  • Albany Stratton VA Medical Center, Albany
  • Bronx Veterans Medical Research Foundation, The Bronx
  • VA Hudson Valley Healthcare System, Wappingers Falls
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 45 e oltre · Tutti i sessi · Aggiornato il 1 lug 2026 · NCT07186296

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699

A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 giu 2026 · NCT07671339

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.